CEL-SCI CEO receives 5,192-share stock grant

CEL-SCI Corp Chief Executive Officer Geert R. Kersten reported a compensation-related acquisition of 5,192 shares of common stock at $1.04 per share.

Rhea-AI Filing Summary

CEL-SCI Corp Chief Executive Officer Geert R. Kersten reported a compensation-related acquisition of 5,192 shares of common stock at $1.04 per share. Following this grant, he directly holds 216,142 common shares and indirectly holds 311,547 common shares as trustee.

Insights

Equity compensation analyst

Routine CEO stock grant with modest size and no sales.

The filing shows CEL-SCI Corp CEO Geert R. Kersten receiving 5,192 shares of common stock at $1.04 per share, classified as a grant, award, or other acquisition. This is standard equity compensation, not an open-market purchase or sale.

After the transaction, Kersten holds 216,142 shares directly and 311,547 shares indirectly as trustee. With no sales or derivative exercises reported and no tax-withholding dispositions, this appears as a routine update to his equity position rather than a directional trading signal.

Insider Trade Summary

Grant/Award: 5,192 shares

Grant/Award 2 txns

Insider KERSTEN GEERT R

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	5,192	$1.04	$5K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 216,142 shares (Direct); Common Stock — 311,547 shares (Indirect, Trustee)

Key Figures

Stock grant size: 5,192 shares Grant price: $1.04 per share Direct holdings after grant: 216,142 shares +1 more

4 metrics

Stock grant size 5,192 shares Common Stock grant to CEO on 2026-06-30

Grant price $1.04 per share Price for granted Common Stock

Direct holdings after grant 216,142 shares CEO direct Common Stock ownership after transaction

Indirect holdings as trustee 311,547 shares CEO indirect Common Stock ownership as trustee after transaction

Key Terms

Grant, award, or other acquisition, Common Stock, Trustee, Form 4

4 terms

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Common Stock financial

"security_title: Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Trustee financial

"nature_of_ownership: Trustee"

A trustee is a person or institution legally appointed to hold and manage assets or enforce an agreement on behalf of other people (beneficiaries). Think of a trustee as a neutral referee or custodian who must act in the beneficiaries’ best interests, follow the trust or contract rules, and handle distributions, recordkeeping and enforcement. Investors care because a trustworthy trustee protects their rights, ensures promised payments or remedies are delivered, and can influence recoveries if things go wrong.

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did CEL-SCI (CVM) CEO Geert Kersten report in this Form 4?

Geert Kersten reported receiving 5,192 shares of CEL-SCI common stock as a grant at $1.04 per share. The transaction is classified as a compensation-related acquisition, not an open-market trade, updating his ownership position in the company.

How many CEL-SCI (CVM) shares does the CEO hold after this filing?

After the reported grant, CEO Geert Kersten directly holds 216,142 CEL-SCI common shares and indirectly holds 311,547 shares as trustee. These figures reflect his updated ownership position as disclosed in the Form 4 for the reported date.

Was the CEL-SCI (CVM) CEO buying or selling shares in the market?

The CEO was not buying or selling shares in the open market. The 5,192 shares were received as a grant, award, or other acquisition at $1.04 per share, which is categorized as compensation-related rather than an open-market trade.

What is the significance of the transaction code "A" in CEL-SCI (CVM) Form 4?

Transaction code "A" indicates a grant, award, or other acquisition of securities. In this Form 4, it shows CEL-SCI’s CEO received 5,192 common shares at $1.04 per share as part of compensation, instead of executing a market purchase or sale.

How many CEL-SCI (CVM) shares does the CEO hold indirectly?

The Form 4 reports that Geert Kersten indirectly holds 311,547 CEL-SCI common shares in a trustee capacity. This indirect ownership is separate from his 216,142 directly held shares and reflects holdings associated with a trust relationship.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/01/2026 - 08:33 AM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KERSTEN GEERT R

(Last) (First) (Middle)

8229 BOONE BLVD

STE 802

(Street)

VIENNA VIRGINIA 22182

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CEL SCI CORP [ CVM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/30/2026		A		5,192	A	$1.04	216,142	D
Common Stock								311,547	I	Trustee

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Geert Kersten	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)